Pharma News, Research & Solutions CSR News

6 Top Questions About COVID-19: What a Child Psychiatrist Has to Say

Summary: 

On the latest episode of "The Road to a Vaccine," host Lisa Ling delves into the effects of the pandemic on kids. We sat down with one of the guests, Vikram Patel, a professor at Harvard Medical School, to find out the most pressing questions on his mind.

Blog

On the latest episode of "The Road to a Vaccine," host Lisa Ling delves into the effects of the pandemic on kids. We sat down with one of the guests, Vikram Patel, a professor at Harvard Medical School, to find out the most pressing questions on his mind.

3 Ways to Pandemic Proof Your Facility

by James P. (JP) Bornholdt, AIA, PE, LEED AP, Process Architect
Blog

Segregation, cleanability, and automation/process closure are proven ways to protect viral containment through a pandemic and beyond.

CRB at Animal Health in the Heartland

Blog

On August 18th, learn from CRB’s subject matter experts covering critical, relevant topics in the animal health market at this year’s Animal Health in the Heartland symposium, where the focus will be “Whole Animal Health.”

Whole Animal Health

4 Latest Facts About Johnson & Johnson's Investigational COVID-19 Vaccine

Summary: 

A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19. We share more about the findings from the recent preclinical study, along with other up-to-date information about the potential vaccine candidate.

Blog

A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19. We share more about the findings from the recent preclinical study, along with other up-to-date information about the potential vaccine candidate.

Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine With the Imbokodo Study

The clinical trial has completed full immunizations of the company's investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19.
Blog

Since the start of the pandemic, Johnson & Johnson has been working to help address the devastating impacts of COVID-19 through the power of its science, the size of its global reach—and the know-how that comes from such experiences as standing up to challenges like HIV.

How Qualcomm Ventures Companies Are Aiding the Fight Against COVID-19

Blog

Staying connected is more important than ever for all of us around the world, and in both our personal and professional lives. Enter wireless technology: It’s helping us keep in touch with friends and family, as well as work and learn remotely. It’s also supporting life-saving telemedicine and is instrumental in getting people food and other immediate resources.

The Road to a Vaccine, Season 2, Ep. 2: How New COVID-19 Outbreaks Are Impacting a Global Return to Normal

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

In Episode 2, Lisa Ling talks with Dr. Francis Collins, Director, NIH about the latest on treatments and vaccines. Also, Harvard's Dr. Ashish Jha shares how the virus affects the body and Johns Hopkins' Dr. Tom Inglesby explains what the new data on spread means for people.

The Road to a Vaccine, Season 2, Ep. 1: How Lessons Learned in Fighting HIV Help Us Battle COVID-19

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

In the Season 2 premiere, Lisa Ling checks into the AIDS 2020 conference to talk with HIV advocate Laverne Cox and Johnson &. Johnson Chief Scientific Officer Paul Stoffels, M.D., about how HIV vaccine research is informing work on COVID-19 vaccines.

Alkermes: Supporting Our Patients During COVID-19

Multimedia with summary

While the COVID-19 pandemic has created so much uncertainty, we remain committed to supporting people living with substance use disorders and schizophrenia and helping to assure that patients have access to our medicines.

Read more here

Medtronic: Leadership During the COVID-19 Crisis

Medtronic CEO talks with TriplePundit about delivering on our Mission during a pandemic
Article

CEO Geoff Martha was recently interviewed by TriplePundit about the company's response to COVID-19. Watch clips of the conversation, where he discusses how our Mission guided him and empowered us to put purpose over profit in a time of crisis.

Watch clips here.

Pages

Subscribe to Pharma News, Research & Solutions